QIMA Life Sciences is a key player in contract research and innovation for the cosmetics, nutraceuticals, dermatology, pharmaceutical, and biotech industries. Our mission is to support biotechs, pharmaceutical laboratories, and leading cosmetic or nutraceutical brands in validating their product claims and discovering new drug candidates through cutting-edge research and testing solutions.

Our division specializes in providing critical testing solutions and R&D services at every stage of cosmetic, nutraceutical and pharmaceutical product development including:

  • Bio-Prediction: Utilizing artificial intelligence (in silico testing), we predict the potential effects of molecules, helping to identify promising candidates early in the development process.

  • Pre-Clinical Efficacy Evaluation: Our scientific teams develop methods, models, and assays that closely mimic healthy or pathological biological systems. These are used to test the efficacy of molecules and compounds, analyze mechanisms of action, and confirm proof of concept. Additionally, we have access to patients for biopsies, allowing us to gather crucial data directly from human tissues, enhancing the relevance and accuracy of our pre-clinical studies. These approaches maximize the generation of clinically predictive results.

  • Clinical Evaluations: We conduct clinical evaluations using advanced techniques such as skin and hair imaging and bioanalysis of clinical samples, ensuring the highest standards of accuracy and reliability. Furthermore, we have access to panels of volunteers for conducting comprehensive clinical studies.

Our division is powered by a network of five laboratories—four in France and one in Germany—offering complementary services to our clients. Altogether, we have over 2000 m² of laboratory space. We are supported by a dedicated team of 150 highly qualified professionals, including 34 PhDs, who are passionate about innovation and excellence. Our culture is centered on:

  • Innovation: Constantly pushing the boundaries to provide cutting-edge solutions.

  • Client Passion: Delivering exceptional service and scientific rigor to meet and exceed client expectations.

  • Collaboration: Engaging closely with our clients to support their research and development efforts.

We recently expanded one of our French labs, enhancing our technical capabilities and improving working conditions. This expansion also reflects our commitment to minimizing our environmental impact and reducing our carbon footprint. We are proud to have achieved a Silver EcoVadis ESG rating at our laboratory in Gençay, underscoring our dedication to environmental sustainability and social responsibility.

Our ultimate goal is patient health, and we collaborate closely with our clients daily to contribute to a healthier future.

QIMA BIOALTERNATIVES

in silico, in vitro & ex vivo Testing / Clinical bioanalysis & analytical chemistry

Cellular & molecular pharmacology / Analytical & bioanalytical exploration

Poitiers | 900m² of laboratories – Toulouse | 250m² of laboratories

Clinical analysis

Image acquisition & analysis

Lyon | 700m² of laboratories

in vitro, ex vivo & in vivo Research & Testing

Focus on Dermatology

Münster | 600m² of laboratories

COMPLEMENTARY EXPERTISE TO MEET THE NEEDS OF THE HEALTH AND BEAUTY INDUSTRIES

2500

square meter laboratory

150

employees

500 +

in vitro and ex vivo assays in our catalog

15 % +

R&D investments

1200 +

studies & customized
studies/year

Find out more about the QIMA Group

QIMA is a leading service provider of laboratory testing solutions, inspection and certification, which works with international brand names, distributors and manufacturers to improve their product quality and compliance.
With 4,000 employees in 85 countries, QIMA is a partner of 14,000 customers in the fields of consumer goods and in the food industry.

>> More information